Abstract:
Coronavirus disease 2019 (COVID-19) outbreak, arisen in Wuhan, China. It is very series disease.Started with pneumonia of unknown etiology whichhave been reported to the World Health Organization (WHO) on 31 December 2019. Novel coronavirus (2019-nCov) was identified and isolated by Chinese health authorities on 7 January 2020, and it was sharing the same receptor, Angiotensin-converting enzyme 2 (ACE2) as SARSCoV,ACE2 RNA expression profile in the normal human lung and ACE2 virus receptor expression is concentrated in a small population of type II alveolar cells. This study highlights important questions regarding the pathophysiology, and treatment options of COVID-2019; firstly, is the dry cough associated with the course of illness of COVID-2019 due to the overproduction of bradykinin? Secondly, is the ARDS and mortality associated with COVID-2019 are due to pneumonia or angioedema like illness?
Page(s):
1085-1086
DOI:
DOI not available
Published:
Journal: Pakistan Journal of Medical and Health Sciences, Volume: 14, Issue: 3, Year: 2020